Insider · CIK 0001485508

Collins Cooper C.

Reports to the SEC for 2 companies · MAGNOLIA, TX

sec.gov

Transactions

Companies

Filings

CIK

0001485508

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-11-03	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Director	AAward	+8,500 sh	—	—	8,500
2025-02-18	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,500 sh	—	—	60,516
2025-02-18	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,500 sh	—	—	0
2024-08-22	TXMDTherapeuticsMD, Inc.P Purchase	Director	PPurchase	+4,094 sh	$1.73	+$7,098.996	52,016
2024-08-21	TXMDTherapeuticsMD, Inc.P Purchase	Director	PPurchase	+1,200 sh	$1.70	+$2,038.56	47,922
2023-07-17	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Director	AAward	+8,500 sh	—	—	8,500
2022-09-29	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Director	AAward	+5,000 sh	—	—	5,000
2022-08-18	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,984 sh	—	—	46,722
2022-08-18	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,984 sh	—	—	0
2021-11-18	TXMDTherapeuticsMD, Inc.P Purchase	Director	PPurchase	+1M sh	$0.58	+$579K	2,236,864
2021-08-18	TXMDTherapeuticsMD, Inc.P Purchase	Director	PPurchase	+900K sh	$0.72	+$648K	1,236,864
2021-08-17	TXMDTherapeuticsMD, Inc.P Purchase	Director	PPurchase	+100K sh	$0.77	+$77K	336,864
2021-08-10	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+96.9K sh	—	—	236,864
2021-08-10	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−96.9K sh	—	—	0
2021-07-01	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Director	AAward	+99.2K sh	—	—	99,174
2020-06-18	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Director	AAward	+96.9K sh	—	—	96,864
2020-06-09	TXMDTherapeuticsMD, Inc.P Purchase	Director	PPurchase	+47.5K sh	$1.45	+$68.9K	140,000
2020-06-08	TXMDTherapeuticsMD, Inc.P Purchase	Director	PPurchase	+26.5K sh	$1.45	+$38.4K	92,500
2019-06-20	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+75K sh	—	—	75,000
2019-05-13	TXMDTherapeuticsMD, Inc.P Purchase	Director	PPurchase	+30K sh	$3.33	+$99.9K	66,000
2018-07-02	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2017-06-21	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2016-12-21	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2016-03-11	TXMDTherapeuticsMD, Inc.P Purchase	Director	PPurchase	+16K sh	$6.23	+$99.7K	36,000
2015-12-17	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2015-03-25	TXMDTherapeuticsMD, Inc. · Non-qualified stock optionA Award	Director	AAward	+100K sh	—	—	100,000
2014-03-04	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−47.2K sh	$3.59	−$169K	6,090,046
2014-03-04	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−3.5M sh	$3.40	−$11.9M	2,590,046
2014-03-03	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−42.8K sh	$3.61	−$155K	6,137,241
2014-02-05	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−1,730 sh	$3.53	−$6,099.461	6,193,116
2014-02-05	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−13.1K sh	$2.56	−$33.5K	6,180,046
2014-02-04	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−42.5K sh	$2.11	−$89.6K	6,194,846
2014-02-03	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−32.7K sh	$2.16	−$70.5K	6,237,346
2014-01-07	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−28K sh	$2.20	−$61.6K	6,270,046
2014-01-06	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−28.4K sh	$2.23	−$63.4K	6,298,008
2014-01-06	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock OptionX Exercise of In-Money	Director	XExercise of In-Money	+70K sh	—	—	220,000
2014-01-03	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−6,195 sh	$2.42	−$15K	6,326,451
2014-01-02	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−27.4K sh	$2.46	−$67.3K	6,332,646
2013-12-06	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−17.5K sh	$2.29	−$40.1K	6,360,046
2013-12-05	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−20K sh	$2.33	−$46.5K	6,377,546
2013-12-04	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−31K sh	$2.38	−$73.9K	6,397,498
2013-12-03	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−7,429 sh	$2.48	−$18.4K	6,428,517
2013-12-02	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−14.1K sh	$2.55	−$35.9K	6,435,946
2013-11-05	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−30.2K sh	$1.99	−$60.3K	6,450,046
2013-11-04	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−15.2K sh	$2.01	−$30.6K	6,480,285
2013-11-01	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−44.6K sh	$2.01	−$89.7K	6,495,485
2013-10-08	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−200 sh	$2.51	−$502	6,540,046
2013-10-07	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−12.4K sh	$2.49	−$30.8K	6,540,246
2013-10-04	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−10.8K sh	$2.45	−$26.4K	6,552,625
2013-10-03	PERNIX THERAPEUTICS HOLDINGS, INC.S Sale	Chief Strategic Officer	SSale	−25.7K sh	$2.46	−$63.3K	6,563,410

Recent filings

Accepted (ET)
Nov 54
Collins Cooper C.0000905148-25-003783
SEC(opens sec.gov)
Feb 204
Collins Cooper C.0000905148-25-000740
SEC(opens sec.gov)
Aug 264
Collins Cooper C.0000905148-24-002363
SEC(opens sec.gov)
Aug 234
Collins Cooper C.0000905148-24-002340
SEC(opens sec.gov)
Jul 194
Collins Cooper C.0001209191-23-042763
SEC(opens sec.gov)
Oct 34
Collins Cooper C.0001209191-22-051955
SEC(opens sec.gov)
Aug 224
Collins Cooper C.0001209191-22-046969
SEC(opens sec.gov)
Nov 224
Collins Cooper C.0001209191-21-066002
SEC(opens sec.gov)
Aug 194
Collins Cooper C.0001387131-21-008733
SEC(opens sec.gov)
Aug 124
Collins Cooper C.0001387131-21-008436
SEC(opens sec.gov)
Jul 24
Collins Cooper C.0001387131-21-007127
SEC(opens sec.gov)
Jun 194
Collins Cooper C.0001387131-20-005816
SEC(opens sec.gov)
Jun 104
Collins Cooper C.0001387131-20-005591
SEC(opens sec.gov)
Jun 244
Collins Cooper C.0001387131-19-004585
SEC(opens sec.gov)
May 154
Collins Cooper C.0001387131-19-003731
SEC(opens sec.gov)

Companies

Address

33219 FOREST WEST DRIVE

MAGNOLIA, TX, 77354